These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 30201690)
1. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells. Chen WX; Xu LY; Qian Q; He X; Peng WT; Zhu YL; Cheng L Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201690 [TBL] [Abstract][Full Text] [Related]
2. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs. Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545 [TBL] [Abstract][Full Text] [Related]
3. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415 [TBL] [Abstract][Full Text] [Related]
4. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes. Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of dysregulated microRNAs in exosomes from docetaxel-resistant and parental human breast cancer cells. Chen WX; Xu LY; Cheng L; Qian Q; He X; Peng WT; Zhu YL Cancer Manag Res; 2019; 11():5425-5435. PubMed ID: 31354350 [No Abstract] [Full Text] [Related]
6. miRNA expression patterns in chemoresistant breast cancer tissues. Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164 [TBL] [Abstract][Full Text] [Related]
7. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364 [TBL] [Abstract][Full Text] [Related]
8. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression. Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975 [TBL] [Abstract][Full Text] [Related]
9. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. Yu DD; Wu Y; Zhang XH; Lv MM; Chen WX; Chen X; Yang SJ; Shen H; Zhong SL; Tang JH; Zhao JH Tumour Biol; 2016 Mar; 37(3):3227-35. PubMed ID: 26432333 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology. Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes. Zhong S; Chen X; Wang D; Zhang X; Shen H; Yang S; Lv M; Tang J; Zhao J Oncotarget; 2016 Apr; 7(15):19601-9. PubMed ID: 26910922 [TBL] [Abstract][Full Text] [Related]
12. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Zhong S; Li W; Chen Z; Xu J; Zhao J Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196 [TBL] [Abstract][Full Text] [Related]
13. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis. Zhao X; Ren Y; Cui N; Wang X; Cui Y Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data. Wang YW; Zhang W; Ma R Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395 [TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin. Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353 [TBL] [Abstract][Full Text] [Related]
17. d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission. Chen WX; Xu LY; Qian Q; He X; Peng WT; Fan WQ; Zhu YL; Tang JH; Cheng L Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061173 [TBL] [Abstract][Full Text] [Related]
18. Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/NOTCH1. Chen NN; Zhou KF; Miao Z; Chen YX; Cui JX; Su SW Mol Cell Probes; 2024 Aug; 76():101964. PubMed ID: 38810840 [TBL] [Abstract][Full Text] [Related]
19. Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer. Wang X; Xu C; Hua Y; Sun L; Cheng K; Jia Z; Han Y; Dong J; Cui Y; Yang Z J Exp Clin Cancer Res; 2016 Dec; 35(1):186. PubMed ID: 27906043 [TBL] [Abstract][Full Text] [Related]
20. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer. Wang L; He M; Fu L; Jin Y Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]